SKI Market

A+| A| A-|

Indian Indices

Sensex

75,415.35 231.99
( 0.31%)

Global Indices

Nasdaq

50,600.73 294.06
(0.58%)

Dow Jones

7,493.73 27.01
(0.36%)

Hang Seng

63,328.42 1,644.28
(2.67%)

Nikkei 225

10,474.02 30.55
(0.29%)

Forex

USD-INR

96.29 -0.42
(-0.43%)

EUR-INR

111.82 -0.44
(-0.39%)

GBP-INR

129.28 -0.40
(-0.31%)

JPY-INR

0.61 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1142.874838

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

29.2

64633.25

EPS(TTM)

Face Value()

Div & Yield %

185.12

0.83

Back

B C C Fuba India standalone net profit rises 18.18% in the December 2025 quarter

Feb 14,2026

Net profit of B C C Fuba India rose 18.18% to Rs 1.17 crore in the quarter ended December 2025 as against Rs 0.99 crore during the previous quarter ended December 2024. Sales rose 29.03% to Rs 17.29 crore in the quarter ended December 2025 as against Rs 13.40 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	17.29	13.40	29
OPM %	14.11	16.27	-
PBDT	2.11	1.97	7
PBT	1.67	1.72	-3
NP	1.17	0.99	18

75,415.35 231.99 ( 0.31%)

50,600.73 294.06 (0.58%)

7,493.73 27.01 (0.36%)

63,328.42 1,644.28 (2.67%)

10,474.02 30.55 (0.29%)

96.29 -0.42 (-0.43%)

111.82 -0.44 (-0.39%)

129.28 -0.40 (-0.31%)

0.61 0.00 (-0.48%)